CDKN2A and gastric cancer: They used 5-azacytidine (V) before EOX (epirubicin, oxaliplatin, capecitabine) neoadjuvant chemotherapy in GC patients and the result showed hypomethylation of tumor-related loci such as HPP1, TIMP3, CDKN2A, ESR1, and MGMT.